Expert consensus on intraarticular injection of autologous apheresis platelet-rich plasma in the treatment of knee osteoarthritis
Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 12
Abstract
Knee osteoarthritis (KOA) is one of the most common musculoskeletal diseases. Platelet-rich plasma (PRP) has been widely used in the treatment of KOA. However, the effectiveness of KOA treatment has been affected due to the large differences in PRP preparation technology, storage method, and intra-articular injection treatment plan. Based on a comprehensive and systematic literature review and clinical practice experience, experts in blood transfusion medicine, orthopedics and rehabilitation medicine and other disciplines (departments) from a number of domestic large-scale tertiary hospitals with experience in the treatment of KOA with apheresis PRP formed this expert consensus by in-depth study. The consensus includes four aspects: the background of the formation of the consensus, the advantages of preparing PRP from autologous platelets apheresis for KOA treatment, the theoretical basis and the frozen storage method of apheresis PRP, and the clinical application scheme of apheresis PRP intraarticular injection for the treatment of KOA. Recommendations are as follows: autologous PRP prepared by platelets apheresis is used to treat KOA by intra-articular injection; the platelet concentration(Plt) in PRP prefers (1 000~1 800)×109/L, the red blood cells(RBC) contamination should be ≤3.2×1010/L, and the leukocytes(WBC) contamination should be ≤2.0×109/ L; PRP is suitable to be stored at -80℃, within 6-months storage; a course of treatment prefers 3 to 4 occasions of injection, with an interval of 1 to 2 weeks; the injection volume of one knee joint could be (4~8)mL/person; the joint effusion should be removed before injection without mixing with anesthetics or corticosteroids; restriction of strenuous exercise for 48 hours after injection is necessary. This consensus is intended to promote the standardized application of autologous apheresis PRP in the treatment of KOA, improve the effectiveness of clinical treatment of KOA and the scientificity of its evaluation, so as to lay a preliminary foundation for formulating standardized guidelines or (and) standards for the treatment of KOA with autologous apheresis PRP in the future.
Authors and Affiliations
Working Party on Clinical Transfusion Management, Chinese Society of Blood Transfusion
Keywords
Related Articles
- EP ID EP738424
- DOI 10.13303/j.cjbt.issn.1004-549x.2022.12.001
- Views 39
- Downloads 0
Study on deoxygenation of polymerized bovine hemoglobin and its effects on the molecular stability
Objective To identify the key factors that regulate the physical vacuum stirring deoxygenation process of bovine hemoglobin and evaluate the stabilities of polyHb solution with different oxygenation degree. Methods The e...
Construction of a system for isolation and purification of NK cells from whole blood donations
[Objective] To explore the feasibility of using whole blood as a source of NK cells for allogeneic CAR NK cell therapy and activated NK cell reinfusion therapy, and initially construct a technical system for the separati...
Reported incidence of adverse reactions in plateletpheresis donors in China: a meta-analysis
Objective To analyze the overall situation and main influencing factors of adverse reactions of blood donation of apheresis platelet donors in China by systematic review, and to provide basis for preventing and controlli...
Analysis of related factors of plasma antibody titer in convalescent patients with COVID-19
Objective To study the relationship between the plasma IgG, IgM, neutralizing antibody titer and sex, age, collection interval in convalescent patients with COVID-19, so as to guide the plasma collection of convalescent...
ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022
Objective To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors. Methods Routine ABO and RhD blood g...